Fluorine in PDB 1dy9: Inhibition of the Hepatitis C Virus NS3/4A Protease. the Crystal Structures of Two Protease-Inhibitor Complexes (Inhibitor I)
Protein crystallography data
The structure of Inhibition of the Hepatitis C Virus NS3/4A Protease. the Crystal Structures of Two Protease-Inhibitor Complexes (Inhibitor I), PDB code: 1dy9
was solved by
S.Di Marco,
M.Rizzi,
C.Volpari,
M.Walsh,
F.Narjes,
S.Colarusso,
R.Defrancesco,
V.G.Matassa,
M.Sollazzo,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
20.00 /
2.10
|
Space group
|
P 61
|
Cell size a, b, c (Å), α, β, γ (°)
|
94.350,
94.350,
82.370,
90.00,
90.00,
120.00
|
R / Rfree (%)
|
21.3 /
27.5
|
Other elements in 1dy9:
The structure of Inhibition of the Hepatitis C Virus NS3/4A Protease. the Crystal Structures of Two Protease-Inhibitor Complexes (Inhibitor I) also contains other interesting chemical elements:
Fluorine Binding Sites:
The binding sites of Fluorine atom in the Inhibition of the Hepatitis C Virus NS3/4A Protease. the Crystal Structures of Two Protease-Inhibitor Complexes (Inhibitor I)
(pdb code 1dy9). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 4 binding sites of Fluorine where determined in the
Inhibition of the Hepatitis C Virus NS3/4A Protease. the Crystal Structures of Two Protease-Inhibitor Complexes (Inhibitor I), PDB code: 1dy9:
Jump to Fluorine binding site number:
1;
2;
3;
4;
Fluorine binding site 1 out
of 4 in 1dy9
Go back to
Fluorine Binding Sites List in 1dy9
Fluorine binding site 1 out
of 4 in the Inhibition of the Hepatitis C Virus NS3/4A Protease. the Crystal Structures of Two Protease-Inhibitor Complexes (Inhibitor I)
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 1 of Inhibition of the Hepatitis C Virus NS3/4A Protease. the Crystal Structures of Two Protease-Inhibitor Complexes (Inhibitor I) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F401
b:50.4
occ:1.00
|
F1
|
A:2ZF401
|
0.0
|
50.4
|
1.0
|
CG2
|
A:2ZF401
|
1.3
|
51.2
|
1.0
|
F2
|
A:2ZF401
|
2.2
|
50.4
|
1.0
|
CB2
|
A:2ZF401
|
2.4
|
50.9
|
1.0
|
CA2
|
A:2ZF401
|
2.7
|
47.2
|
1.0
|
O
|
A:2ZF401
|
3.2
|
54.9
|
1.0
|
N2
|
A:2ZF401
|
3.4
|
42.6
|
1.0
|
CZ
|
A:PHE154
|
3.5
|
27.7
|
1.0
|
N
|
A:ALA157
|
3.7
|
36.6
|
1.0
|
CB
|
A:ALA157
|
3.7
|
32.3
|
1.0
|
CE2
|
A:PHE154
|
3.8
|
25.6
|
1.0
|
C5
|
A:2ZF401
|
4.0
|
46.2
|
1.0
|
O3
|
A:2ZF401
|
4.1
|
47.2
|
1.0
|
C6
|
A:2ZF401
|
4.1
|
45.0
|
1.0
|
CB
|
A:LEU135
|
4.3
|
34.2
|
1.0
|
CA
|
A:ALA157
|
4.3
|
38.0
|
1.0
|
CG2
|
A:VAL132
|
4.4
|
49.7
|
1.0
|
C
|
A:ALA156
|
4.4
|
35.7
|
1.0
|
CD3
|
A:2ZF401
|
4.4
|
45.5
|
1.0
|
O
|
A:LEU135
|
4.4
|
35.6
|
1.0
|
C4
|
A:2ZF401
|
4.4
|
55.1
|
1.0
|
CA
|
A:ALA156
|
4.4
|
33.1
|
1.0
|
OG
|
A:SER139
|
4.5
|
34.6
|
1.0
|
CE1
|
A:PHE154
|
4.5
|
30.3
|
1.0
|
C
|
A:LEU135
|
4.6
|
40.2
|
1.0
|
OE11
|
A:2ZF401
|
4.7
|
49.1
|
1.0
|
N
|
A:LYS136
|
4.8
|
38.8
|
1.0
|
CA
|
A:LYS136
|
5.0
|
38.4
|
1.0
|
NZ
|
A:LYS136
|
5.0
|
49.3
|
1.0
|
|
Fluorine binding site 2 out
of 4 in 1dy9
Go back to
Fluorine Binding Sites List in 1dy9
Fluorine binding site 2 out
of 4 in the Inhibition of the Hepatitis C Virus NS3/4A Protease. the Crystal Structures of Two Protease-Inhibitor Complexes (Inhibitor I)
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 2 of Inhibition of the Hepatitis C Virus NS3/4A Protease. the Crystal Structures of Two Protease-Inhibitor Complexes (Inhibitor I) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F401
b:50.4
occ:1.00
|
F2
|
A:2ZF401
|
0.0
|
50.4
|
1.0
|
CG2
|
A:2ZF401
|
1.4
|
51.2
|
1.0
|
F1
|
A:2ZF401
|
2.2
|
50.4
|
1.0
|
CB2
|
A:2ZF401
|
2.4
|
50.9
|
1.0
|
NZ
|
A:LYS136
|
3.0
|
49.3
|
1.0
|
CE
|
A:LYS136
|
3.1
|
47.0
|
1.0
|
O3
|
A:2ZF401
|
3.4
|
47.2
|
1.0
|
CD
|
A:LYS136
|
3.5
|
45.1
|
1.0
|
CA2
|
A:2ZF401
|
3.5
|
47.2
|
1.0
|
O
|
A:2ZF401
|
3.6
|
54.9
|
1.0
|
CG2
|
A:VAL132
|
3.8
|
49.7
|
1.0
|
CG
|
A:LYS136
|
3.9
|
43.8
|
1.0
|
C5
|
A:2ZF401
|
4.0
|
46.2
|
1.0
|
N2
|
A:2ZF401
|
4.0
|
42.6
|
1.0
|
OE11
|
A:2ZF401
|
4.3
|
49.1
|
1.0
|
CA
|
A:LYS136
|
4.3
|
38.4
|
1.0
|
C4
|
A:2ZF401
|
4.4
|
55.1
|
1.0
|
N
|
A:LYS136
|
4.4
|
38.8
|
1.0
|
CD3
|
A:2ZF401
|
4.6
|
45.5
|
1.0
|
CB
|
A:LYS136
|
4.6
|
43.5
|
1.0
|
CB
|
A:2ZF401
|
4.7
|
64.4
|
1.0
|
CB
|
A:ALA157
|
4.7
|
32.3
|
1.0
|
C6
|
A:2ZF401
|
4.8
|
45.0
|
1.0
|
C
|
A:LEU135
|
4.8
|
40.2
|
1.0
|
O
|
A:VAL132
|
4.8
|
40.1
|
1.0
|
|
Fluorine binding site 3 out
of 4 in 1dy9
Go back to
Fluorine Binding Sites List in 1dy9
Fluorine binding site 3 out
of 4 in the Inhibition of the Hepatitis C Virus NS3/4A Protease. the Crystal Structures of Two Protease-Inhibitor Complexes (Inhibitor I)
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 3 of Inhibition of the Hepatitis C Virus NS3/4A Protease. the Crystal Structures of Two Protease-Inhibitor Complexes (Inhibitor I) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F401
b:51.2
occ:1.00
|
F1
|
B:2ZF401
|
0.0
|
51.2
|
1.0
|
CG2
|
B:2ZF401
|
1.3
|
49.7
|
1.0
|
F2
|
B:2ZF401
|
2.2
|
48.2
|
1.0
|
CB2
|
B:2ZF401
|
2.4
|
48.8
|
1.0
|
O
|
B:2ZF401
|
2.7
|
42.7
|
1.0
|
CA2
|
B:2ZF401
|
2.9
|
42.7
|
1.0
|
N2
|
B:2ZF401
|
2.9
|
40.7
|
1.0
|
N
|
B:ALA157
|
3.4
|
32.2
|
1.0
|
C5
|
B:2ZF401
|
3.5
|
41.9
|
1.0
|
CB
|
B:ALA157
|
3.6
|
31.5
|
1.0
|
O3
|
B:2ZF401
|
3.7
|
38.1
|
1.0
|
CZ
|
B:PHE154
|
3.7
|
24.0
|
1.0
|
C4
|
B:2ZF401
|
3.8
|
46.3
|
1.0
|
CA
|
B:ALA156
|
3.9
|
31.3
|
1.0
|
C
|
B:ALA156
|
4.0
|
33.3
|
1.0
|
CA
|
B:ALA157
|
4.1
|
34.9
|
1.0
|
CE2
|
B:PHE154
|
4.1
|
26.6
|
1.0
|
C6
|
B:2ZF401
|
4.3
|
41.1
|
1.0
|
CA1
|
B:2ZF401
|
4.4
|
42.8
|
1.0
|
N1
|
B:2ZF401
|
4.5
|
44.5
|
1.0
|
OG
|
B:SER139
|
4.6
|
29.5
|
1.0
|
CE1
|
B:PHE154
|
4.6
|
27.6
|
1.0
|
O
|
B:ARG155
|
4.7
|
34.4
|
1.0
|
CB
|
B:LEU135
|
4.7
|
31.3
|
1.0
|
N
|
B:ALA156
|
4.8
|
30.9
|
1.0
|
CG2
|
B:VAL132
|
4.8
|
49.7
|
1.0
|
CB
|
B:ALA156
|
4.8
|
35.0
|
1.0
|
CB
|
B:2ZF401
|
4.8
|
51.9
|
1.0
|
NZ
|
B:LYS136
|
4.8
|
42.5
|
1.0
|
CG
|
B:2ZF401
|
4.8
|
56.0
|
1.0
|
CD3
|
B:2ZF401
|
4.9
|
41.0
|
1.0
|
CA
|
B:2ZF401
|
4.9
|
49.0
|
1.0
|
OE11
|
B:2ZF401
|
5.0
|
43.1
|
1.0
|
|
Fluorine binding site 4 out
of 4 in 1dy9
Go back to
Fluorine Binding Sites List in 1dy9
Fluorine binding site 4 out
of 4 in the Inhibition of the Hepatitis C Virus NS3/4A Protease. the Crystal Structures of Two Protease-Inhibitor Complexes (Inhibitor I)
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 4 of Inhibition of the Hepatitis C Virus NS3/4A Protease. the Crystal Structures of Two Protease-Inhibitor Complexes (Inhibitor I) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F401
b:48.2
occ:1.00
|
F2
|
B:2ZF401
|
0.0
|
48.2
|
1.0
|
CG2
|
B:2ZF401
|
1.4
|
49.7
|
1.0
|
F1
|
B:2ZF401
|
2.2
|
51.2
|
1.0
|
CB2
|
B:2ZF401
|
2.4
|
48.8
|
1.0
|
CE
|
B:LYS136
|
2.9
|
43.1
|
1.0
|
NZ
|
B:LYS136
|
3.0
|
42.5
|
1.0
|
CA2
|
B:2ZF401
|
3.3
|
42.7
|
1.0
|
CD
|
B:LYS136
|
3.4
|
42.2
|
1.0
|
O3
|
B:2ZF401
|
3.4
|
38.1
|
1.0
|
CG2
|
B:VAL132
|
3.6
|
49.7
|
1.0
|
N2
|
B:2ZF401
|
3.8
|
40.7
|
1.0
|
O
|
B:2ZF401
|
3.9
|
42.7
|
1.0
|
CG
|
B:LYS136
|
3.9
|
34.9
|
1.0
|
C5
|
B:2ZF401
|
4.0
|
41.9
|
1.0
|
CA
|
B:LYS136
|
4.1
|
32.7
|
1.0
|
N
|
B:LYS136
|
4.1
|
35.6
|
1.0
|
OE11
|
B:2ZF401
|
4.2
|
43.1
|
1.0
|
CG
|
B:2ZF401
|
4.4
|
56.0
|
1.0
|
O
|
B:VAL132
|
4.4
|
33.9
|
1.0
|
C
|
B:LEU135
|
4.5
|
37.5
|
1.0
|
CB
|
B:LYS136
|
4.6
|
36.7
|
1.0
|
CD3
|
B:2ZF401
|
4.6
|
41.0
|
1.0
|
C6
|
B:2ZF401
|
4.6
|
41.1
|
1.0
|
CB
|
B:ALA157
|
4.7
|
31.5
|
1.0
|
O
|
B:LEU135
|
4.7
|
35.4
|
1.0
|
CB
|
B:LEU135
|
4.7
|
31.3
|
1.0
|
C4
|
B:2ZF401
|
4.7
|
46.3
|
1.0
|
CB
|
B:2ZF401
|
4.8
|
51.9
|
1.0
|
OE2
|
B:2ZF401
|
5.0
|
61.7
|
1.0
|
|
Reference:
S.Di Marco,
M.Rizzi,
C.Volpari,
M.Walsh,
F.Narjes,
S.Colarusso,
R.De Francesco,
V.G.Matassa,
M.Sollazzo.
Inhibition of the Hepatitis C Virus NS3/4A Protease the Crystal Structures of Two Protease-Inhibitor Complexes J.Biol.Chem. V. 275 7152 2000.
ISSN: ISSN 0021-9258
PubMed: 10702283
DOI: 10.1074/JBC.275.10.7152
Page generated: Wed Jul 31 11:07:40 2024
|